Tuesday, 10 December 2019

Correvio's heart drug fails to win FDA panel backing

Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp's drug to correct irregular rhythm in the upper chambers of the heart in adult patients.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)